Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

QUITACHIEVE LIFE SCIENCES, INC.

Nasdaq · CIK 0000949858
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2835 In Vitro & In Vivo Diagnostic Substances
FY end1231
XBRL facts368

Identity from submissions API

NameACHIEVE LIFE SCIENCES, INC.
CIK0000949858
TickersQUIT, ACHV
ExchangesNasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2835 In Vitro & In Vivo Diagnostic Substances
EIN954343413
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone425-686-1500
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ONCOGENEX PHARMACEUTICALS, INC. (2008-08-21T04:00:00.000Z → 2017-07-31T04:00:00.000Z)
  • SONUS PHARMACEUTICALS INC (1996-05-24T04:00:00.000Z → 2008-08-07T04:00:00.000Z)
Business address
22722 29TH DR. SE
SUITE 100
SEATTLE
WA
98021
WA
Mailing address
22722 29TH DR. SE
SUITE 100
SEATTLE
WA
98021
WA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1362 filing rows loaded from submissions recent; extra archives: CIK0000949858-submissions-001.json (361 filings, 1996-05-24 to 2009-05-11).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000088 005-45969 261563133 34 18368
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005358 005-45969 261561417 34 10712
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000597 005-45969 261560186 34 29372
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000595 005-45969 261560075 34 29564
2026-11-10 10-Q 10-Q 0001193125-26-455463 033-80623 261540455 34 12641768 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-455404 033-80623 261540203 34 646502 1 1
2026-10-06 4 xslF345X06/form4-10062026_081008.xml 0001953943-26-000004 8462
2026-10-06 3 xslF345X06/form3-10062026_081053.xml 0001953943-26-000002 11684
2026-10-01 8-K 8-K 5.02 0001193125-26-410781 033-80623 261432133 34 209462 1 1
2026-08-21 4 4 0001193125-26-361182 6766
2026-08-19 144 xsl144X01/primary_doc.xml 0001949846-26-000528 033-80623 261293020 33 5477
2026-08-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000426 005-45969 261288144 34 29068
2026-08-14 8-K 8-K 8.01,9.01 0001193125-26-352229 033-80623 261281526 34 728934 1 1
2026-08-14 424B5 424B5 0001193125-26-352154 333-292918 261281090 33 472459
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000193 005-45969 261271642 34 13281
2026-08-11 10-Q 10-Q 0001193125-26-344624 033-80623 261263254 34 11836723 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-344571 033-80623 261263090 34 547417 1 1
2026-07-29 4 4 0001193125-26-324262 8050
2026-07-29 4 4 0001193125-26-324256 8097
2026-07-29 4 4 0001193125-26-324253 8999
2026-07-29 4 4 0001193125-26-324250 8083
2026-07-29 4 4 0001193125-26-324245 8072
2026-07-29 4 4 0001193125-26-324238 8049
2026-07-29 4 4 0001193125-26-324231 8089
2026-07-28 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000038777-26-000201 005-45969 261209455 34 22080
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002256 005-45969 261206084 34 11017
2026-07-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-076390 005-45969 261162703 34 32562
2026-07-06 8-K 8-K 5.03,5.07,9.01 0001193125-26-296174 033-80623 261155902 34 316374 1 1
2026-06-08 ARS ARS 0000949858-26-000007 033-80623 261072652 34 798572
2026-06-08 DEF 14A DEF 14A 0000949858-26-000006 033-80623 261072629 34 13459107 1 1
2026-06-02 4 4 0002107415-26-000004 5598
2026-06-02 4 4 0001405253-26-000011 5569
2026-06-02 3 3 0002107415-26-000003 17360
2026-06-02 3 3 0001405253-26-000010 17334
2026-06-02 8-K 8-K 5.02 0001193125-26-252624 033-80623 261053765 34 198489 1 1
2026-05-29 PRE 14A PRE 14A 0001193125-26-248338 033-80623 261044665 34 3582554 1 1
2026-05-21 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001729 333-295798 261010634 33 1979
2026-05-19 CORRESP filename1.htm 0001193125-26-230847 12280
2026-05-18 UPLOAD filename1.pdf 0000000000-26-005091 333-295798 148134
2026-05-13 4 4 0001193125-26-221774 5611
2026-05-13 3 3 0001193125-26-221733 17384
2026-05-12 S-8 S-8 0001193125-26-219443 333-295799 26968652 33 866781 1 1
2026-05-12 S-3 S-3 0001193125-26-219441 333-295798 26968647 33 915992 1 1
2026-05-12 10-Q 10-Q 0001193125-26-218177 033-80623 26965869 34 8701324 1 1
2026-05-12 8-K 8-K 2.02,5.02,9.01 0001193125-26-218175 033-80623 26965868 34 251830 1 1
2026-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000038777-26-000122 005-45969 26951994 34 18185
2026-04-30 10-K/A 10-K/A 0001193125-26-197402 033-80623 26925784 34 4562295 1 1
2026-04-27 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000905148-26-001871 005-45969 26902269 34 43543
2026-04-27 3 3 0001193125-26-182197 18478
2026-04-24 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-048793 005-45969 26896233 34 17246
2026-04-24 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001999371-26-009036 005-45969 26895559 34 26341
2026-04-24 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001999371-26-009035 12997
2026-04-24 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001999371-26-009032 3996
2026-04-24 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000406 005-45969 26895335 34 33792
2026-04-24 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000040 005-45969 26894058 34 35631
2026-04-21 4 4 0001193125-26-167418 11068
2026-04-21 3 3 0001193125-26-167404 18112
2026-04-16 8-K 8-K 1.01,3.02,5.02,7.01,9.01 0001193125-26-159189 033-80623 26868218 34 1509539 1 1
2026-04-16 S-8 S-8 0001193125-26-159016 333-295099 26867682 33 879378 1 1
2026-03-24 S-8 S-8 0001193125-26-121817 333-294565 26786332 33 521526 1 1
2026-03-24 10-K 10-K 0001193125-26-120690 033-80623 26784153 34 16993112 1 1
2026-03-24 8-K 8-K 2.02,9.01 0001193125-26-120687 033-80623 26784144 34 541526 1 1
2026-01-30 4 4 0001193125-26-031806 5586
2026-01-30 4 4 0001193125-26-031801 5585
2026-01-30 4 4 0001193125-26-031795 5557
2026-01-30 4 4 0001193125-26-031790 5568
2026-01-30 4 4 0001193125-26-031782 5585
2026-01-30 4 4 0001193125-26-031761 5686
2026-01-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000355 333-292918 26580319 33 1978
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-26-000017 005-45969 26575833 34 22006
2026-01-27 CORRESP filename1.htm 0001193125-26-024893 13031
2026-01-27 UPLOAD filename1.pdf 0000000000-26-000975 333-292918 40336
2026-01-23 S-3 S-3 0001193125-26-021032 333-292918 26556340 33 1579222 1 1
2026-01-12 3 3 0001193125-26-009831 20404
2025-12-08 4 4 0001193125-25-311199 5598
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005187 005-45969 251489018 34 10945
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001013594-25-001417 005-45969 251482642 34 14322
2025-11-06 10-Q 10-Q 0001193125-25-268074 033-80623 251456135 34 9629574 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-268056 033-80623 251456116 34 536866 1 1
2025-10-21 3 3 0001193125-25-245268 17999
2025-10-07 8-K 8-K 5.02 0001193125-25-233581 033-80623 251380409 34 197977 1 1
2025-10-03 4 4 0001193125-25-230324 5572
2025-09-22 4 4 0001193125-25-211404 9464
2025-09-22 4 4 0001193125-25-211392 13009
2025-09-19 3 3 0001193125-25-208411 18689
2025-09-11 8-K 8-K 5.02 0001193125-25-201418 033-80623 251309284 34 194691 1 1
2025-09-08 4 4 0000950170-25-113606 5993
2025-09-08 4 4 0000950170-25-113598 8268
2025-09-08 4 4 0000950170-25-113592 12511
2025-09-08 4 4 0000950170-25-113591 9681
2025-09-08 4 4 0000950170-25-113588 12384
2025-09-08 4 4 0000950170-25-113581 12076
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003543 005-45969 251221187 34 11342
2025-08-07 10-Q 10-Q 0000950170-25-104571 033-80623 251191653 34 9255097 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-104569 033-80623 251191641 34 533646 1 1
2025-08-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-25-000138 005-45969 251183414 34 22353
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002528 005-45969 251128483 34 10911
2025-06-27 8-K 8-K 1.01,8.01,9.01 0000950170-25-091055 033-80623 251088059 34 1253834 1 1
2025-06-27 424B5 424B5 0000950170-25-090991 333-280585 251087421 33 582278
2025-06-26 424B5 424B5 0000950170-25-090401 333-280585 251080535 33 592881
2025-06-10 4 4 0000950170-25-084439 5381
2025-06-10 4 4 0000950170-25-084427 5353
2025-06-10 4 4 0000950170-25-084423 5369
2025-06-10 4 4 0000950170-25-084420 5411
2025-06-10 4 4 0000950170-25-084415 5359
2025-06-10 4 4 0000950170-25-084407 5363
2025-06-06 8-K 8-K 5.07 0000950170-25-083214 033-80623 251031816 34 258466 1 1
2025-05-13 10-Q 10-Q 0000950170-25-069806 033-80623 25937166 34 8146490 1 1
2025-05-13 8-K 8-K 2.02,9.01 0000950170-25-069804 033-80623 25937152 34 454481 1 1
2025-05-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-25-000080 005-45969 25929370 34 18498
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000503 005-45969 25891982 34 6439
2025-04-28 ARS ARS 0000950170-25-059300 033-80623 25880404 34 675523
2025-04-28 DEF 14A DEF 14A 0000950170-25-059297 033-80623 25880382 34 9357062 1 1
2025-03-19 4 4 0000950170-25-042074 5185
2025-03-19 4 4 0000950170-25-042060 6533
2025-03-11 10-K 10-K 0000950170-25-036831 033-80623 25725869 34 15226098 1 1
2025-03-11 8-K 8-K 2.02,9.01 0000950170-25-036830 033-80623 25725865 34 526486 1 1
2025-02-10 8-K 8-K 8.01,9.01 0000950170-25-017068 033-80623 25605846 34 262499 1 1
2025-01-30 4 4 0000950170-25-011164 5878
2025-01-30 4 4 0000950170-25-011159 5749
2025-01-30 4 4 0000950170-25-011156 5749
2025-01-14 4 4 0000950170-25-005405 5450
2025-01-14 4 4 0000950170-25-005404 5419
2025-01-14 4 4 0000950170-25-005398 8125
2025-01-14 4 4 0000950170-25-005392 8028
2025-01-14 4 4 0000950170-25-005389 5558
2025-01-14 3 3 0000950170-25-005386 15393
2025-01-14 3 3 0000950170-25-005384 15410
2025-01-10 S-8 S-8 0000950170-25-004143 333-284208 25522898 33 304418
2025-01-10 8-K 8-K 5.02 0000950170-25-003873 033-80623 25520820 34 203927 1 1
2024-12-09 4 4 0000950170-24-134606 5418
2024-12-09 4 4 0000950170-24-134600 7951
2024-12-09 3 3 0000950170-24-134598 17527
2024-12-09 8-K 8-K 5.02 0000950170-24-134558 033-80623 241535389 34 207269 1 1
2024-12-05 S-8 S-8 0000950170-24-133703 333-283630 241529385 33 890627
2024-11-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-18 16:00:00 9999999995-24-003509 333-283070 241473218 33 1986
2024-11-14 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0000950170-24-123407,2024-11-14 9999999995-24-003484 333-272641 241465703 33 1999
2024-11-14 CORRESP filename1.htm 0000950170-24-127037 11710
2024-11-14 UPLOAD filename1.pdf 0000000000-24-012621 333-283070 40274
2024-11-12 SC 13G/A UnitedStates_13G__AchieveLif.txt 0000932471-24-000823 005-45969 241445948 34 6794
2024-11-07 S-3 S-3 0000950170-24-123443 333-283070 241436543 33 446455
2024-11-07 POS AM POS AM 0000950170-24-123407 333-272641 241436239 33 48120
2024-11-07 10-Q 10-Q 0000950170-24-123375 033-80623 241435983 34 8938713 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-123334 033-80623 241435764 34 463314 1 1
2024-11-04 SC 13G UnitedStates_13G__AchieveLif.txt 0000932471-24-000265 005-45969 241421379 34 5825
2024-10-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-24-000151 005-45969 241414084 34 26475
2024-10-25 SC 13G us0044685008_102524.txt 0002012383-24-002386 005-45969 241397653 34 13829
2024-10-25 3 3 0000950170-24-117426 27635
2024-09-27 8-K 8-K 1.01,9.01 0000950170-24-110066 033-80623 241335722 34 658107 1 1
2024-09-27 424B5 424B5 0000950170-24-110059 333-280585 241335605 33 452530
2024-08-26 8-K 8-K 5.02,8.01 0001193125-24-207129 033-80623 241241951 34 201761 1 1
2024-08-20 4 4 0000950170-24-099091 4946
2024-08-20 4 4 0000950170-24-099082 4853
2024-08-20 4 4 0000950170-24-099074 4826
2024-08-13 10-Q 10-Q 0000950170-24-096193 033-80623 241201459 34 8051294 1 1
2024-08-13 8-K 8-K 2.02,9.01 0000950170-24-096171 033-80623 241201394 34 460134 1 1
2024-07-29 8-K 8-K 1.01,2.03,3.02,9.01 0000950170-24-087118 033-80623 241149025 34 1448281 1 1
2024-07-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-08 16:00:00 9999999995-24-002096 333-280585 241106243 33 1986
2024-07-03 UPLOAD filename1.pdf 0000000000-24-007621 333-280585 40289
2024-07-03 CORRESP filename1.htm 0000950170-24-081532 11589
2024-06-28 S-3 S-3 0000950170-24-079095 333-280585 241086214 33 1135794
2024-06-27 8-K 8-K 7.01 0000950170-24-078445 033-80623 241079247 34 200065 1 1
2024-06-06 8-K 8-K 5.07 0000950170-24-069973 033-80623 241026352 34 239851 1 1
2024-05-20 SC 13G/A AMENDMENT NO. 2 TO THE 13G 0001013594-24-000500 005-45969 24965520 34 147846
2024-05-17 SC 13G SC 13G 0001829126-24-003471 005-45969 24959124 34 164379
2024-05-09 10-Q 10-Q 0000950170-24-056929 033-80623 24930581 34 6846197 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056876 033-80623 24930407 34 393630 1 1
2024-05-06 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-06 16:00:00 9999999995-24-001397 333-278961 24919413 33 1985
2024-05-02 CORRESP filename1.htm 0001193125-24-129355 7858
2024-05-02 UPLOAD filename1.pdf 0000000000-24-004997 333-278961 40509
2024-04-26 S-3 S-3 0000950170-24-049223 333-278961 24884458 33 456383
2024-04-26 ARS ARS 0000950170-24-049101 033-80623 24883637 34 646191
2024-04-26 DEF 14A DEF 14A 0000950170-24-049089 033-80623 24883535 34 2788496
2024-04-23 4 4 0000950170-24-046984 9018
2024-04-23 4 4 0000950170-24-046974 8890
2024-04-23 4 4 0000950170-24-046962 8974
2024-04-23 4 4 0000950170-24-046936 8863
2024-03-28 S-8 S-8 0000950170-24-038136 333-278335 24799915 33 334142
2024-03-28 10-K 10-K 0000950170-24-038049 033-80623 24799087 34 12480287 1 1
2024-03-28 8-K 8-K 2.02,9.01 0000950170-24-038030 033-80623 24798844 34 451962 1 1
2024-03-11 SC 13G achi24in.htm 0000038777-24-000051 005-45969 24737410 34 204429
2024-03-06 4 4 0000950170-24-027261 7578
2024-03-06 4 4 0000950170-24-027243 7757
2024-02-29 8-K 8-K 1.01,1.02,2.02,3.02,7.01,9.01 0000950170-24-023189 033-80623 24704531 34 1087358 1 1
2024-02-29 424B5 424B5 0000950170-24-023106 333-261811 24703873 33 521386
2024-02-27 SC 13G d10982711_13g.htm 0000919574-24-001753 005-45969 24686012 34 100939
2024-01-29 4 FORM 4 SUBMISSION 0001209191-24-002333 5665
2024-01-24 4 FORM 4 SUBMISSION 0001209191-24-002207 5613
2024-01-24 4 FORM 4 SUBMISSION 0001209191-24-002205 5617
2024-01-24 4 FORM 4 SUBMISSION 0001209191-24-002202 5623
2024-01-24 4 FORM 4 SUBMISSION 0001209191-24-002200 5643
2024-01-24 4 FORM 4 SUBMISSION 0001209191-24-002198 8422
2024-01-24 4 FORM 4 SUBMISSION 0001209191-24-002196 8377
2024-01-24 4 FORM 4 SUBMISSION 0001209191-24-002194 8291
2024-01-24 4 FORM 4 SUBMISSION 0001209191-24-002192 8266
2023-12-11 8-K 8-K 8.01 0000950170-23-069392 033-80623 231478137 34 206896 1 1
2023-11-09 10-Q 10-Q 0000950170-23-062028 033-80623 231392413 34 8440221 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-062005 033-80623 231392251 34 519528 1 1
2023-08-14 10-Q 10-Q 0000950170-23-042401 033-80623 231170081 34 8931756 1 1
2023-08-14 8-K 8-K 2.02,9.01 0000950170-23-042382 033-80623 231169926 34 571258 1 1
2023-06-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-06-23 16:00:00 9999999995-23-001841 333-272641 231039329 33 1937
2023-06-21 CORRESP filename1.htm 0001193125-23-171172 8704
2023-06-20 UPLOAD filename1.pdf 0000000000-23-006575 40451
2023-06-14 S-3 S-3 0001193125-23-166872 333-272641 231014317 33 233330
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035791 5549
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035793 5566
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035786 5852
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035785 5846
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035787 5842
2023-06-09 8-K 8-K 5.03,5.07,9.01 0001193125-23-164423 033-80623 231005146 34 239574 1 1
2023-06-02 SC 13G/A Contrarian_Achieve_13GA.txt 0001921222-23-000001 005-45969 23990185 34 18488
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033392 5041
2023-05-25 424B5 424B5 0000950170-23-024217 333-261811 23960469 33 576790
2023-05-25 8-K 8-K 1.01,7.01,9.01 0000950170-23-024074 033-80623 23956647 34 722860 1 1
2023-05-23 8-K 8-K 7.01,8.01,9.01 0000950170-23-023533 033-80623 23946465 34 10493104 1 1
2023-05-17 8-K 8-K 1.01,2.03,9.01 0000950170-23-022609 033-80623 23929672 34 1757746 1 1
2023-05-16 10-K/A 10-K/A 0000950170-23-022462 033-80623 23927503 34 1292086 1 1
2023-05-09 10-Q 10-Q 0000950170-23-019680 033-80623 23902159 34 7933841 1 1
2023-05-09 8-K 8-K 2.02,9.01 0000950170-23-019679 033-80623 23902149 34 466484 1 1
2023-05-03 8-K 8-K 7.01 0000950170-23-017164 033-80623 23883708 34 218138 1 1
2023-05-01 4 FORM 4 SUBMISSION 0001209191-23-026322 9482
2023-05-01 4 FORM 4 SUBMISSION 0001209191-23-026321 9353
2023-05-01 4 FORM 4 SUBMISSION 0001209191-23-026319 9326
2023-05-01 4 FORM 4 SUBMISSION 0001209191-23-026318 10955
2023-04-28 ARS ARS 0001193125-23-125223 033-80623 23861801 34 2077146
2023-04-28 DEF 14A DEF 14A 0001193125-23-125216 033-80623 23861784 34 1907683
2023-04-25 4/A FORM 4/A SUBMISSION 0001209191-23-025536 5410
2023-04-25 4/A FORM 4/A SUBMISSION 0001209191-23-025534 5438
2023-04-24 4 FORM 4 SUBMISSION 0001209191-23-025384 9486
2023-04-24 4 FORM 4 SUBMISSION 0001209191-23-025383 10963
2023-04-24 4 FORM 4 SUBMISSION 0001209191-23-025381 9361
2023-04-24 4 FORM 4 SUBMISSION 0001209191-23-025380 9333
2023-04-18 SC 13G SCHEDULE 13G 0000921895-23-000896 005-45969 23827797 34 162929
2023-04-18 PRE 14A PRE 14A 0001193125-23-104996 033-80623 23826958 34 1878960
2023-03-30 4 FORM 4 SUBMISSION 0001209191-23-021586 5504
2023-03-30 4 FORM 4 SUBMISSION 0001209191-23-021585 5494
2023-03-30 4 FORM 4 SUBMISSION 0001209191-23-021584 5498
2023-03-30 3 FORM 3 SUBMISSION 0001209191-23-021580 7767
2023-03-30 3 FORM 3 SUBMISSION 0001209191-23-021578 7772
2023-03-30 3 FORM 3 SUBMISSION 0001209191-23-021576 7765
2023-03-30 8-K 8-K 5.02,7.01,9.01 0001564590-23-004687 033-80623 23777228 34 248797 1 1
2023-03-23 8-K 8-K 1.01,9.01 0001564590-23-004277 033-80623 23756988 34 201169 1 1
2023-03-23 SC 13D/A AMENDMENT NO. 2 TO THE SCHEDULE 13D 0000921895-23-000754 005-45969 23756811 34 398771
2023-03-16 S-8 S-8 0001564590-23-003819 333-270625 23739747 33 286678
2023-03-16 10-K 10-K 0001564590-23-003800 033-80623 23739222 34 14525137 1 1
2023-03-16 8-K 8-K 2.02,9.01 0001564590-23-003792 033-80623 23738815 34 513258 1 1
2023-03-06 SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-23-000642 005-45969 23707920 34 6238851
2023-03-06 8-K 8-K 1.01,9.01 0001564590-23-003159 033-80623 23707411 34 263979 1 1
2023-02-13 SC 13G/A achv_13gv5.htm 0001349205-23-000003 005-45969 23619096 34 86361
2023-02-10 SC 13G/A SC 13G/A 0001193125-23-032536 005-45969 23611747 34 106744
2023-01-27 4 FORM 4 SUBMISSION 0001209191-23-005291 8387
2023-01-27 4 FORM 4 SUBMISSION 0001209191-23-005288 8339
2023-01-27 4 FORM 4 SUBMISSION 0001209191-23-005286 8256
2023-01-27 4 FORM 4 SUBMISSION 0001209191-23-005282 8234
2023-01-20 SC 13D SCHEDULE 13D 0000921895-23-000151 005-45969 23540731 34 182773
2023-01-12 424B7 424B7 0001193125-23-007185 333-269059 23526001 33 177310
2023-01-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-01-11 16:00:00 9999999995-23-000082 333-269059 23524843 33 1936
2023-01-05 CORRESP filename1.htm 0001193125-23-001896 9298
2023-01-04 UPLOAD filename1.pdf 0000000000-23-000097 40424
2023-01-03 S-3/A S-3/A 0001193125-23-000179 333-269059 23500069 33 69500
2022-12-30 DEL AM DEL AM 0001193125-22-315419 333-269059 221502042 33 5347
2022-12-29 S-3 S-3 0001193125-22-314743 333-269059 221498911 33 281857
2022-12-08 D/A xslFormDX01/primary_doc.xml 06b 0001168404-22-000004 021-465960 221451271 33 14231
2022-11-29 D xslFormDX01/primary_doc.xml 06b 0001168404-22-000003 021-465960 221427815 33 14130
2022-11-28 SC 13G 13G 0001956207-22-000001 005-45969 221421945 34 21474
2022-11-25 8-K 8-K 3.01 0001564590-22-038292 033-80623 221419455 34 164539 1 1
2022-11-22 4 FORM 4 SUBMISSION 0000899243-22-036700 11267
2022-11-22 SC 13G/A SC 13G/A 0001193125-22-291052 005-45969 221410236 34 106367
2022-11-21 3 OWNERSHIP DOCUMENT 0001104659-22-120805 15361
2022-11-21 SC 13G SC 13G 0001104659-22-120788 005-45969 221406272 34 72268
2022-11-21 4 FORM 4 SUBMISSION 0001209191-22-058064 7372
2022-11-18 8-K 8-K 1.01,3.02,8.01,9.01 0001564590-22-038025 033-80623 221401967 34 841397 1 1
2022-11-14 10-Q 10-Q 0001564590-22-037646 033-80623 221386598 34 7849795 1 1
2022-11-14 8-K 8-K 2.02,9.01 0001564590-22-037625 033-80623 221385601 34 519341 1 1
2022-11-02 4 FORM 4 SUBMISSION 0000899243-22-034753 25269
2022-10-04 4 FORM 4 SUBMISSION 0000899243-22-032637 25270
2022-09-01 4 FORM 4 SUBMISSION 0000899243-22-030171 25339
2022-08-18 4 FORM 4 SUBMISSION 0001209191-22-046649 4883
2022-08-18 4 FORM 4 SUBMISSION 0001209191-22-046647 4910
2022-08-18 4 FORM 4 SUBMISSION 0001209191-22-046644 6819
2022-08-11 10-Q 10-Q 0001564590-22-029122 033-80623 221155841 34 7676324 1 1
2022-08-11 8-K 8-K 2.02,9.01 0001564590-22-029119 033-80623 221155728 34 567319 1 1
2022-08-02 4 FORM 4 SUBMISSION 0000899243-22-027432 26011
2022-07-05 4 FORM 4 SUBMISSION 0000899243-22-025002 25315
2022-06-03 4 FORM 4 SUBMISSION 0000899243-22-021084 25236
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033137 5531
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033135 5530
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033133 5526
2022-06-01 4 FORM 4 SUBMISSION 0001209191-22-033132 5364
2022-06-01 8-K 8-K 5.07 0001564590-22-022030 033-80623 22987339 34 212221 1 1
2022-05-12 10-Q 10-Q 0001564590-22-019876 033-80623 22918080 34 6575029 1 1
2022-05-12 8-K 8-K 2.02,9.01 0001564590-22-019857 033-80623 22917857 34 372877 1 1
2022-05-11 4 FORM 4 SUBMISSION 0000899243-22-017540 25219
2022-04-29 4 FORM 4 SUBMISSION 0001209191-22-026291 10888
2022-04-29 4 FORM 4 SUBMISSION 0001209191-22-026289 9452
2022-04-29 4 FORM 4 SUBMISSION 0001209191-22-026287 10926
2022-04-29 4 FORM 4 SUBMISSION 0001209191-22-026283 9322
2022-04-29 4 FORM 4 SUBMISSION 0001209191-22-026273 9297
2022-04-27 8-K 8-K 1.01,2.03,8.01,9.01 0001564590-22-015873 033-80623 22856426 34 3993102 1 1
2022-04-21 DEF 14A DEF 14A 0001193125-22-112972 033-80623 22841395 34 681773
2022-04-05 4 FORM 4 SUBMISSION 0000899243-22-013792 25261
2022-03-16 4 FORM 4 SUBMISSION 0001209191-22-019220 5472
2022-03-16 3 FORM 3 SUBMISSION 0001209191-22-019211 7799
2022-03-15 8-K 8-K 5.02 0001564590-22-010148 033-80623 22738121 34 165467 1 1
2022-03-10 S-8 S-8 0001564590-22-009644 333-263421 22729189 33 480894
2022-03-10 10-K 10-K 0001564590-22-009485 033-80623 22727509 34 14115806 1 1
2022-03-10 8-K 8-K 2.02,9.01 0001564590-22-009483 033-80623 22727491 34 552121 1 1
2022-03-02 4 FORM 4 SUBMISSION 0000899243-22-008590 25261
2022-02-14 SC 13G/A achv_13gv2.htm 0001349205-22-000002 005-45969 22629251 34 79110
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004561 25264
2022-01-10 4 FORM 4 SUBMISSION 0001209191-22-002724 8237
2022-01-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-01-05 16:00:00 9999999995-22-000049 333-261811 22513560 33 1936
2022-01-05 4 FORM 4 SUBMISSION 0000899243-22-000997 25218
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001728 8327
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001711 8196
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001695 8279
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001671 8168
2022-01-03 CORRESP filename1.htm 0001564590-22-000028 13389
2021-12-30 CORRESP filename1.htm 0001564590-21-061679 13439
2021-12-29 3 FORM 3 SUBMISSION 0000899243-21-050025 20376
2021-12-29 SC 13G SC 13G 0001193125-21-369109 005-45969 211528814 34 109674
2021-12-28 UPLOAD filename1.pdf 0000000000-21-015416 40450
2021-12-22 DEL AM DEL AM 0001193125-21-365023 333-261811 211513618 33 5384
2021-12-22 8-K 8-K 1.01,2.03,9.01 0001564590-21-060919 033-80623 211511056 34 1167475 1 1
2021-12-21 S-3 S-3 0001564590-21-060882 333-261811 211510099 33 1850404
2021-11-09 10-Q 10-Q 0001564590-21-055729 033-80623 211392290 34 7458986 1 1
2021-11-09 8-K 8-K 2.02,9.01 0001564590-21-055716 033-80623 211392171 34 527063 1 1
2021-08-19 4 FORM 4 SUBMISSION 0001209191-21-052578 9275
2021-08-19 4 FORM 4 SUBMISSION 0001209191-21-052573 9301
2021-08-19 4 FORM 4 SUBMISSION 0001209191-21-052568 9430
2021-08-12 10-Q 10-Q 0001564590-21-043972 033-80623 211167655 34 7044723 1 1
2021-08-12 8-K 8-K 2.02,9.01 0001564590-21-043960 033-80623 211167489 34 370370
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036229 5081
2021-05-25 8-K 8-K 1.01,8.01,9.01 0001564590-21-029769 033-80623 21960722 34 338540
2021-05-25 424B5 424B5 0001564590-21-029756 333-229019 21960619 33 665574
2021-05-24 424B5 424B5 0001564590-21-029507 333-229019 21954912 33 667091
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032339 5362
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032335 5524
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032331 5529
2021-05-13 10-Q 10-Q 0001564590-21-027556 033-80623 21919832 34 5368966 1
2021-05-13 8-K 8-K 2.02,5.07,9.01 0001564590-21-027542 033-80623 21919661 34 312037
2021-03-30 DEF 14A DEF 14A 0001193125-21-100219 033-80623 21786594 34 644964
2021-03-17 4 FORM 4 SUBMISSION 0001209191-21-021393 5488
2021-03-17 3 FORM 3 SUBMISSION 0001209191-21-021371 7819
2021-03-15 8-K 8-K 5.02,9.01 0001564590-21-013150 033-80623 21741516 34 85339
2021-03-11 S-8 S-8 0001564590-21-012555 333-254156 21733864 33 246805
2021-03-11 10-K 10-K 0001564590-21-012523 033-80623 21733526 34 13166610 1
2021-03-11 8-K 8-K 2.02,9.01 0001564590-21-012502 033-80623 21733348 34 359989
2021-02-17 SC 13G/A formsc13ga.htm 0001493152-21-004070 005-45969 21641769 34 172263
2021-02-16 SC 13G/A achv_13g.htm 0001349205-21-000003 005-45969 21636873 34 79371
2021-02-16 SC 13G/A SCHEDULE 13G/A 0001104659-21-023211 005-45969 21633623 34 74544
2021-02-12 SC 13G/A formsc13ga.htm 0001493152-21-003637 005-45969 21627163 34 172645
2021-01-28 4 FORM 4 SUBMISSION 0001209191-21-005889 8236
2021-01-28 4 FORM 4 SUBMISSION 0001209191-21-005887 8273
2021-01-28 4 FORM 4 SUBMISSION 0001209191-21-005883 8187
2021-01-28 4 FORM 4 SUBMISSION 0001209191-21-005881 8231
2021-01-28 4 FORM 4 SUBMISSION 0001209191-21-005879 8162
2021-01-07 SC 13G ACHV.htm 0001349205-21-000001 005-45969 21514073 34 94288
2020-12-04 SC 13G formsc13g.htm 0001493152-20-022942 005-45969 201369462 34 165418
2020-12-04 424B4 424B4 0001564590-20-056113 333-250074 201368269 33 437934
2020-12-02 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-12-02 16:30:00 9999999995-20-003366 333-250074 201365578 33 1935
2020-12-02 S-1MEF S-1MEF 0001564590-20-055951 333-251088 201365445 33 129975
2020-11-30 CORRESP filename1.htm 0001564590-20-055594 12293
2020-11-30 FWP FWP 0001564590-20-055569 333-250074 201356262 34 2761789
2020-11-30 S-1/A S-1/A 0001564590-20-055567 333-250074 201356254 33 1582405
2020-11-18 4 FORM 4 SUBMISSION 0001209191-20-059147 5757
2020-11-18 4 FORM 4 SUBMISSION 0001209191-20-059141 5758
2020-11-18 4 FORM 4 SUBMISSION 0001209191-20-059134 5794
2020-11-18 4 FORM 4 SUBMISSION 0001209191-20-059129 5711
2020-11-18 UPLOAD filename1.pdf 0000000000-20-011065 40449
2020-11-18 4 FORM 4 SUBMISSION 0001209191-20-059123 5683
2020-11-13 S-1 S-1 0001564590-20-053884 333-250074 201311559 33 1065348
2020-11-12 10-Q 10-Q 0001564590-20-053567 033-80623 201306819 34 7317809 1
2020-11-12 8-K 8-K 2.02,9.01 0001564590-20-053554 033-80623 201306683 34 355477
2020-10-22 8-K 8-K 7.01,9.01 0001564590-20-047181 033-80623 201251855 34 76287
2020-10-21 8-K 8-K 1.02 0001564590-20-047026 033-80623 201249732 34 29636
2020-10-13 3 FORM 3 SUBMISSION 0001209191-20-054595 7858
2020-09-30 8-K 8-K 5.02 0001564590-20-045191 033-80623 201210661 34 36424
2020-08-20 8-K 8-K 8.01 0001564590-20-040801 033-80623 201120088 34 27832
2020-08-19 4 FORM 4 SUBMISSION 0001209191-20-047495 9915
2020-08-19 4 FORM 4 SUBMISSION 0001209191-20-047494 9922
2020-08-06 10-Q 10-Q 0001564590-20-037768 033-80623 201081932 34 6824528 1
2020-08-06 8-K 8-K 2.02,9.01 0001564590-20-037738 033-80623 201081712 34 354845
2020-08-04 8-K 8-K 1.01,9.01 0001564590-20-036208 033-80623 201074611 34 416200
2020-08-04 424B5 424B5 0001564590-20-036203 333-229019 201074562 33 673612
2020-08-03 424B5 424B5 0001564590-20-035502 333-229019 201069275 33 692346
2020-07-30 8-K 8-K 5.03,8.01,9.01 0001564590-20-034593 033-80623 201059813 34 55591
2020-06-29 424B5 424B5 0001564590-20-030917 333-229019 20996137 33 610419
2020-06-29 8-K 8-K 1.01,9.01 0000950123-20-006480 033-80623 20996090 34 338316
2020-06-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-06-16 16:00:00 9999999995-20-001449 333-238970 20967995 33 1934
2020-06-12 CORRESP filename1.htm 0001564590-20-029165 12946
2020-06-11 UPLOAD filename1.pdf 0000000000-20-005201 40513
2020-06-05 S-1 S-1 0001564590-20-028496 333-238970 20946569 33 896929
2020-05-19 S-8 S-8 0001564590-20-026177 333-238505 20894094 33 424741
2020-05-14 4 FORM 4 SUBMISSION 0001209191-20-029165 5527
2020-05-14 4 FORM 4 SUBMISSION 0001209191-20-029159 5491
2020-05-14 4 FORM 4 SUBMISSION 0001209191-20-029153 5365
2020-05-14 4 FORM 4 SUBMISSION 0001209191-20-029150 5679
2020-05-14 4 FORM 4 SUBMISSION 0001209191-20-029145 5532
2020-05-14 10-Q 10-Q 0001564590-20-025275 033-80623 20875312 34 5731124 1

Latest XBRL company facts

One latest value per concept from companyfacts (368 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 110.03M 2026-11-10 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
dei EntityPublicFloat Entity Public Float USD 103.96M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001193125-26-197402
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.74M 2025-01-01 2025-12-31 DEF 14A 2026-06-08 0000949858-26-000006
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 964,002 2025-01-01 2025-12-31 DEF 14A 2026-06-08 0000949858-26-000006
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.20M 2024-01-01 2024-12-31 DEF 14A 2026-06-08 0000949858-26-000006
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.52M 2024-01-01 2024-12-31 DEF 14A 2026-06-08 0000949858-26-000006
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 202.86 2025-01-01 2025-12-31 DEF 14A 2026-06-08 0000949858-26-000006
ffd NetFeeAmt NetFeeAmt USD 69,069 2026-05-12 S-3 2026-05-12 0001193125-26-219441
ffd TtlFeeAmt TtlFeeAmt USD 69,069 2026-05-12 S-3 2026-05-12 0001193125-26-219441
ffd TtlOfferingAmt TtlOfferingAmt USD 500.14M 2026-05-12 S-3 2026-05-12 0001193125-26-219441
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-12 S-3 2026-05-12 0001193125-26-219441
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-12 S-3 2026-05-12 0001193125-26-219441
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 7.92M 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196104
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.94M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268074
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 8,000 2019-12-31 2020 Q2 10-Q 2020-08-06 0001564590-20-037768
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 200,000 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344624
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 1.03M 2016-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 253,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -166,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 537.99M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AdjustmentForAmortization Amortization USD 223,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001564590-22-009485
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD -2.52M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460518
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 7.70M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 4,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-10 0001564590-22-009485
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 200,000 2012-01-01 2012-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 35,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 100,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218177
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 87.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 202,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002109
us-gaap Assets Assets USD 206.42M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AssetsCurrent Assets, Current USD 203.41M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 32.73M 2016-09-30 2016 Q3 10-Q 2016-11-10 0001564590-16-028946
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 170,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 143.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) USD 94.30M 2012-06-30 2012 Q2 10-Q 2012-08-02 0001193125-12-331889
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year USD 94.30M 2012-06-30 2012 Q2 10-Q 2012-08-02 0001193125-12-331889
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year USD 94.27M 2012-06-30 2012 Q2 10-Q 2012-08-02 0001193125-12-331889
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value USD 94.27M 2012-06-30 2012 Q2 10-Q 2012-08-02 0001193125-12-331889
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 143.78M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 760,000 2017-03-31 2017 Q1 10-Q 2017-05-15 0001564590-17-010905
us-gaap BusinessCombinationBargainPurchaseGainRecognizedAmount Business Combination, Bargain Purchase, Gain Recognized, Amount USD 1.27M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -150,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 699,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123375
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 1.27M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218177
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 218,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002109
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 11,000 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007838
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 12,000 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007838
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due CAD 127,000 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months CAD 51,000 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 79,000 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460518
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years CAD 76,000 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap Cash Cash USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 59.74M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 19.70M 2016-09-30 2016 Q3 10-Q 2016-11-10 0001564590-16-028946
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 8.01M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023285
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 201.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 4.44M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012461
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 59.76M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 38.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 18.28M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 80 2018-06-19 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.59M 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-300691
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 109.78M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 109.78M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CommonStockValue Common Stock, Value, Issued USD 177,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -97.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ContractualObligation Contractual Obligation USD 1.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 5,000 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap ContractualObligationDueInFourthAndFifthYear Contractual Obligation, to be Paid, Year Four and Five USD 5,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053567
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 363,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ContractualObligationDueInSecondAndThirdYear Contractual Obligation, to be Paid, Year Two and Three USD 779,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 53,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053567
us-gaap ConvertibleDebt Convertible Debt USD 16.66M 2023-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 7.45M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 17.59M 2024-06-30 2024 Q2 10-Q 2024-08-13 0000950170-24-096193
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 5.59M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap CostsAndExpenses Costs and Expenses USD 49.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 2.00M 2015-05-13 2015-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.023 2023-05-15 2024 Q1 10-Q 2024-05-09 0000950170-24-056929
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 15.00M 2023-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.07 2023-05-15 2024 Q2 10-Q 2024-08-13 0000950170-24-096193
us-gaap DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance shares 2.38M 2013-09-30 2013 Q3 10-Q 2013-11-07 0001193125-13-432841
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 1.14M 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 5,000 2023-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -3.05M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 283,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 5.04M 2015-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002109
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2011-12-31 2011 FY 10-K 2012-03-08 0001193125-12-103884
us-gaap DeferredRevenueRevenueRecognized Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) USD 30.00M 2012-01-01 2012-12-31 2015 FY 10-K 2016-03-09 0001564590-16-014302
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 51,000 2012-12-31 2013 FY 10-K 2014-03-11 0001193125-14-093757
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 90.71M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 283,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 64.86M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.26M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 899,000 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 12.42M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.59M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 164,000 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges USD -25,000 2014-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002010
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 90.42M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 124,000 2016-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 474,000 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 124,000 2016-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 283,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap Depreciation Depreciation USD 27,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001564590-22-009485
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 178,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 71,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460518
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 829,000 2016-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.8 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019876
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.199 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 4,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001564590-19-019424
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.18M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 22.20M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 41.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012461
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 6.53M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002010
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases USD 150,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 16,000 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030879
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 20,000 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030879
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 82,000 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 223,000 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218177
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 168,000 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218177
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 223,000 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-040673
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 82,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 82,000 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218177
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 223,000 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-218177
us-gaap FiniteLivedIntangibleAssetsFairValueDisclosure Finite-lived Intangible Assets, Fair Value Disclosure USD 3.10M 2015-05-18 2026 Q1 10-Q 2026-05-12 0001193125-26-218177
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 584,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -4,000 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023285
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD 107,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD -8.61M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -283,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 21.02M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268074
us-gaap Goodwill Goodwill USD 1.03M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 111,000 2023-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap GuaranteeObligationsCurrentCarryingValue Guarantor Obligations, Current Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -54.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -54.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -456,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002109
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD -3.00M 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-07 0001193125-13-096041
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 10.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -169,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -14,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -11.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 906,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 265,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 17,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -221,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-10 0001564590-22-009485
us-gaap IncomeTaxReconciliationTaxCreditsInvestment Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Amount USD 134,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001564590-22-009485
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 839,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 875,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196104
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD -7,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268074
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -8,000 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-12 0001564590-21-043972
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -32,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -307,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030879
us-gaap IncreaseDecreaseInAccruedSalaries Increase (Decrease) in Accrued Salaries USD -1.03M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD -404,000 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -5.04M 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 1.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 1.23M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268074
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 643,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-07 0001193125-13-096041
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 9,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-040673
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -136,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268074
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -140,000 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD 21,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002109
us-gaap IncreaseDecreaseInRestructuringReserve Increase (Decrease) in Restructuring Reserve USD -194,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002109
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 2.38M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460518
us-gaap InterestExpense Interest Expense USD 1.98M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123375
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 809,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 2.31M 2023-12-31 2024 FY 10-K 2025-03-11 0000950170-25-036831
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 32,000 2016-12-31 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 3.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 1.03M 2010-01-01 2010-12-31 2011 FY 10-K 2012-03-08 0001193125-12-103884
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 300,000 2014-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002010
us-gaap Liabilities Liabilities USD 25.69M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 206.42M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap LiabilitiesCurrent Liabilities, Current USD 19.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD -131,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 22.00M 2009-01-01 2009-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002109
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 1.38M 2016-06-30 2016 Q2 10-Q 2016-08-04 0001564590-16-022738
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 1.38M 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 141.78M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) USD 0 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-07 0001193125-13-432841
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 190.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 1.10M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012461
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -125.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 10,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012461
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -26.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -2.23M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012461
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -97.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -14.67M 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-08 0001193125-12-103884
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) USD 3,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap NonmonetaryTransactionAmountOfBarterTransaction Nonmonetary Transaction, Amount of Barter Transaction USD 0 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002010
us-gaap NonmonetaryTransactionGainLossRecognizedOnTransfer Nonmonetary Transaction, Gain (Loss) Recognized on Transfer USD 151,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002010
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -47.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap OperatingExpenses Operating Expenses USD 7.37M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-12 0001564590-16-019250
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 19.74M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460518
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 61,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344624
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 286,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 712,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap OperatingLeasePayments Operating Lease, Payments USD 46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 974,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 100,000 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389643
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 25,000 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389643
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 75,000 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389643
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year CAD 26,000 2013-09-30 2013 Q3 10-Q 2013-11-07 0001193125-13-432841
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 200,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.092 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 34.80M 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.80M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268074
us-gaap OtherAssetsCurrent Other Assets, Current USD 158,000 2016-09-30 2016 Q3 10-Q 2016-11-10 0001564590-16-028946
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 187,000 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax (Deprecated 2012-01-31) USD -4,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-08 0001193125-12-103884
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -176,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 4,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007838
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 1,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-07 0001193125-13-096041
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -176,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) USD -5,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-03 0001193125-12-208535
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 6,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-11 0001193125-14-093757
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 1,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 166,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 151,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-11 0001193125-14-093757
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 29,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030879
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -34,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD 4,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 10.00M 2009-12-01 2009-12-31 2012 Q3 10-Q 2012-11-08 0001193125-12-460518
us-gaap PaymentsForRestructuring Payments for Restructuring USD 2.07M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 20,000 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019680
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 100,000 2015-04-26 2015-04-27 2016 FY 10-K 2017-02-23 0001564590-17-002109
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap PaymentsToAcquireAdditionalInterestInSubsidiaries Payments to Acquire Additional Interest in Subsidiaries USD 2.00M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 170,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 24.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 172.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 49,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 19.45M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-26 0001564590-15-002010
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-040673
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-040673
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.94M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268074
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 173,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 662,000 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 9.81M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 100,000 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023285
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 57.50M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-07 0001193125-13-096041
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 64,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 168.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 10,000 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 13,800 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028073
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 423,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030879
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 10.23M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 150,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007838
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 47.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 30.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 10,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 1.00M 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-23 0001564590-17-002109
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 970,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 160,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 22.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -97.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 256,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 3,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ReimbursementRevenue Reimbursement Revenue (Deprecated 2018-01-31) USD 5.06M 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-09 0001564590-16-014302
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 1.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 272,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 19.12M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268074
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 15.10M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460518
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 57.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 222,000 2017-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004159
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 50,000 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 222,000 2017-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007838
us-gaap RestructuringAndRelatedCostExpectedCostRemaining1 Restructuring and Related Cost, Expected Cost Remaining USD 2.21M 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Position 5 2016-11-01 2016-11-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.48 2016-10-01 2016-10-31 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap RestructuringCharges Restructuring Charges USD 431,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-12 0001564590-16-019250
us-gaap RestructuringCosts Restructuring Costs USD -267,000 2014-10-01 2014-12-31 2015 FY 10-K 2016-03-09 0001564590-16-014302
us-gaap RestructuringReserve Restructuring Reserve USD 28,000 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD -107,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 1.06M 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap RestructuringReserveNoncurrent Restructuring Reserve, Noncurrent USD 3.19M 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326864
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -357.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 978,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap RoyaltyExpense Royalty Expense USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-07 0001193125-13-096041
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 12 2012-03-21 2014 FY 10-K 2015-03-26 0001564590-15-002010
us-gaap SeveranceCosts1 Severance Costs USD 700,000 2016-11-01 2016-11-30 2017 Q2 10-Q 2017-07-31 0001564590-17-014488
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 13.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 0 2017-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020508
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.769 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.04M 2013-09-30 2013 Q3 10-Q 2013-11-07 0001193125-13-432841
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 200,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 20 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 827,993 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 7.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.81 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.40M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.45M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.31 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) USD 1.60M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-07 0001193125-13-096041
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.00M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 2,200 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 4.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 9.33 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 1.57M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 2.73M 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 7.08 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ShortTermInvestments Short-term Investments USD 33.37M 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123375
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 180.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.05 2020-07-31 2022 FY 10-K 2023-03-16 0001564590-23-003800
us-gaap StockIssued1 Stock Issued USD 254,000 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-10 0001564590-16-028946
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 1.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 228,225 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 7.90M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-08 0001193125-12-103884
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 13.05M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010642
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 160,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 273,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -1,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038049
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 915,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 761,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 24,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-11 0001193125-14-093757
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 5,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities USD 38,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012523
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 800,000 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 8.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001193125-26-120690
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 3,000 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023285
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 84.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 9.46M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019876
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 84.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455463

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →